subject: CHEBI:177298

object_name: carcinoma of esophagus


subject: CHEBI:177298

object_name: esophageal cancer

tested_intervention: unsure


subject: CHEBI:177298

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:177298

object_name: neoplasm of esophagus


subject: CHEBI:176844

subject_name: Niraparib

object_name: esophageal adenocarcinoma


subject: CHEBI:176844

object_name: lung adenocarcinoma


subject: CHEBI:176844

object_name: cervical adenocarcinoma


subject: CHEBI:176844

object_name: adenocarcinoma


subject: CHEBI:176844

object_name: bile duct adenocarcinoma


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:16664

subject_name: Albendazole

object_name: epilepsy


subject: CHEBI:45267

subject_name: praziquantel


subject: CHEBI:91583

subject_name: Praziquantel


subject: UMLS:C1765344

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: CHEBI:31909

subject_name: Nifekalant hydrochloride

object_name: ventricular tachycardia


subject: CHEBI:31909

object_name: Ventricular Tachycardia, CTCAE 3.0


subject: CHEBI:31909

object_name: continuous electrocardiogram ventricular tachycardia


subject: CHEBI:31909

object_name: Ventricular Tachycardia by ECG Finding


subject: CHEBI:31909

object_name: Ventricular Tachycardia, CTCAE 5.0


subject: CHEBI:31909

object_name: ventricular fibrillation


subject: CHEBI:31909

object_name: Ventricular Fibrillation by ECG Finding


subject: CHEBI:31909

object_name: continuous electrocardiogram ventricular fibrillation


subject: CHEBI:31909

object_name: Ventricular Fibrillation, CTCAE 3.0


subject: CHEBI:31909

object_name: Ventricular Fibrillation, CTCAE 5.0


subject: UMLS:C0171476

subject_name: nifekalant hydrochloride


subject: UMLS:C0171476


subject: UMLS:C0171476


subject: UMLS:C0171476


subject: UMLS:C0171476


subject: UMLS:C0171476


subject: UMLS:C0171476


subject: UMLS:C0171476


subject: UMLS:C0171476


subject: UMLS:C0171476


subject: CHEBI:94575

subject_name: Nifekalant


subject: CHEBI:94575


subject: CHEBI:94575


subject: CHEBI:94575


subject: CHEBI:94575


subject: CHEBI:94575


subject: CHEBI:94575


subject: CHEBI:94575


subject: CHEBI:94575


subject: CHEBI:94575


subject: CHEBI:231614

subject_name: Nivolumab

object_name: cancer of unknown primary site


subject: UMLS:C2346820


subject: CHEBI:231679

subject_name: ipilimumab


subject: UNII:0125DUV5XC

subject_name: varlilumab

object_name: Burkitt-like lymphoma with 11q aberration


subject: UNII:0125DUV5XC

object_name: ALK-positive large B-cell lymphoma


subject: UNII:0125DUV5XC

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UNII:0125DUV5XC

object_name: Diffuse large B-cell lymphoma recurrent


subject: UNII:0125DUV5XC

object_name: B-cell lymphoma refractory


subject: UNII:0125DUV5XC

object_name: Burkitt's lymphoma refractory


subject: UNII:0125DUV5XC

object_name: intravascular large B-cell lymphoma


subject: UNII:0125DUV5XC

object_name: B-cell lymphoma recurrent


subject: UNII:0125DUV5XC

object_name: Refractory Gray-Zone Lymphoma


subject: UNII:0125DUV5XC

object_name: Recurrent Burkitt Lymphoma


subject: UNII:0125DUV5XC

object_name: Recurrent Childhood Burkitt Lymphoma


subject: UNII:0125DUV5XC

object_name: Recurrent Adult Burkitt Lymphoma


subject: UNII:0125DUV5XC

object_name: Large B-cell lymphoma with IRF4 rearrangement


subject: UNII:0125DUV5XC

object_name: Recurrent Gray-Zone Lymphoma


subject: UNII:0125DUV5XC

object_name: High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:0125DUV5XC

object_name: Recurrent Lymphomatoid Granulomatosis


subject: UNII:0125DUV5XC

object_name: Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: UNII:0125DUV5XC

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: UNII:0125DUV5XC

object_name: Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: UNII:0125DUV5XC

object_name: diffuse large B-cell lymphoma


subject: UNII:0125DUV5XC

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: UNII:0125DUV5XC

object_name: high grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement


subject: UNII:0125DUV5XC

object_name: Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UNII:0125DUV5XC

object_name: Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UNII:0125DUV5XC

object_name: diffuse large B-cell lymphoma activated B-cell type


subject: UNII:0125DUV5XC

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UNII:0125DUV5XC

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UNII:0125DUV5XC

object_name: diffuse large B-cell lymphoma of the central nervous system


subject: UNII:0125DUV5XC

object_name: diffuse large B-cell lymphoma germinal center B-cell type


subject: UNII:0125DUV5XC

object_name: HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:0125DUV5XC

object_name: Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly


subject: UNII:0125DUV5XC

object_name: Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: UNII:0125DUV5XC

object_name: plasmablastic lymphoma


subject: UNII:0125DUV5XC

object_name: large-cell immunoblastic lymphoma


subject: UNII:0125DUV5XC

object_name: Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: UNII:0125DUV5XC

object_name: diffuse large B-cell lymphoma with chronic inflammation


subject: UNII:0125DUV5XC

object_name: primary effusion lymphoma


subject: UNII:0125DUV5XC

object_name: EBV positive mucocutaneous ulcer


subject: UMLS:C3274549

object_name: Burkitt-like lymphoma with 11q aberration


subject: UMLS:C3274549

object_name: ALK-positive large B-cell lymphoma


subject: UMLS:C3274549

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UMLS:C3274549

object_name: Diffuse large B-cell lymphoma recurrent


subject: UMLS:C3274549

object_name: B-cell lymphoma refractory


subject: UMLS:C3274549

object_name: Burkitt's lymphoma refractory


subject: UMLS:C3274549

object_name: intravascular large B-cell lymphoma


subject: UMLS:C3274549

object_name: B-cell lymphoma recurrent


subject: UMLS:C3274549

object_name: Refractory Gray-Zone Lymphoma


subject: UMLS:C3274549

object_name: Recurrent Burkitt Lymphoma


subject: UMLS:C3274549

object_name: Recurrent Childhood Burkitt Lymphoma


subject: UMLS:C3274549

object_name: Recurrent Adult Burkitt Lymphoma


subject: UMLS:C3274549

object_name: Large B-cell lymphoma with IRF4 rearrangement


subject: UMLS:C3274549

object_name: Recurrent Gray-Zone Lymphoma


subject: UMLS:C3274549

object_name: High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C3274549

object_name: Recurrent Lymphomatoid Granulomatosis


subject: UMLS:C3274549

object_name: Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: UMLS:C3274549

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: UMLS:C3274549

object_name: Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: UMLS:C3274549

object_name: diffuse large B-cell lymphoma


subject: UMLS:C3274549

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: UMLS:C3274549

object_name: high grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement


subject: UMLS:C3274549

object_name: Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UMLS:C3274549

object_name: Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UMLS:C3274549

object_name: diffuse large B-cell lymphoma activated B-cell type


subject: UMLS:C3274549

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UMLS:C3274549

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UMLS:C3274549

object_name: diffuse large B-cell lymphoma of the central nervous system


subject: UMLS:C3274549

object_name: diffuse large B-cell lymphoma germinal center B-cell type


subject: UMLS:C3274549

object_name: HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C3274549

object_name: Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly


subject: UMLS:C3274549

object_name: Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: UMLS:C3274549

object_name: plasmablastic lymphoma


subject: UMLS:C3274549

object_name: large-cell immunoblastic lymphoma


subject: UMLS:C3274549

object_name: Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: UMLS:C3274549

object_name: diffuse large B-cell lymphoma with chronic inflammation


subject: UMLS:C3274549

object_name: primary effusion lymphoma


subject: UMLS:C3274549

object_name: EBV positive mucocutaneous ulcer


subject: CHEBI:75934

subject_name: Vadimezan

object_name: Solid Neoplasm

tested_intervention: yes


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: neurofibromatosis


subject: CHEBI:32016

object_name: neurofibroma


subject: UNII:TBF1NHY02O

subject_name: AMCENESTRANT

object_name: Carcinoma breast stage IV


subject: UMLS:C4687517


subject: UMLS:C5421014

subject_name: Amcenestrant


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: high-grade B-cell lymphoma double-hit/triple-hit


subject: CHEBI:135918

object_name: mantle cell lymphoma


subject: UNII:660M185X4D


subject: UMLS:C0964361

subject_name: SonoVue

object_name: fetal growth restriction


subject: CHEBI:30496

subject_name: Sulfur hexafluoride


subject: MESH:C552724

subject_name: OKN 007

object_name: glioblastoma


subject: MESH:C552724

object_name: Childhood Glioblastoma


subject: MESH:C552724

object_name: adult glioblastoma


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Advanced Bile Duct Carcinoma


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: alcohol abuse


subject: UMLS:C5554952

object_name: Malignant ascites


subject: MESH:C074705

subject_name: milk-derived factor

object_name: Child Malnutrition


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant

object_name: Childhood Breast Carcinoma


subject: DRUGBANK:DB17475

object_name: breast carcinoma


subject: DRUGBANK:DB17475

object_name: breast cancer


subject: MESH:C477385

subject_name: montanide ISA 51


subject: MESH:C477385


subject: MESH:C477385


subject: CHEBI:6062

subject_name: Isosorbide mononitrate

object_name: anus disorder


subject: CHEBI:6062

object_name: anal fissure on exam (physical finding)


subject: CHEBI:6062

object_name: Anal Fissure, CTCAE


subject: CHEBI:6062

object_name: Anal fissure


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: psoriasis vulgaris


subject: CHEBI:9150

subject_name: Simvastatin

object_name: adult lymphoma


subject: CHEBI:9150

object_name: lymphoma


subject: CHEBI:9150

object_name: pediatric lymphoma


subject: CHEBI:135696

subject_name: Altropane

object_name: Parkinson disease


subject: CHEBI:135696

object_name: movement disorder


subject: CHEBI:16382

subject_name: Iodide


subject: CHEBI:16382


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: Other specified congenital malformations of heart


subject: CHEBI:31300

object_name: hypoplastic left heart syndrome


subject: CHEBI:31300

object_name: tricuspid atresia


subject: CHEBI:51450

subject_name: Bosentan


subject: CHEBI:51450


subject: CHEBI:51450


subject: UMLS:C5959091

subject_name: Anti-PD-1/Anti-CD73 Bispecific Antibody AK131

object_name: Childhood Solid Neoplasm


subject: UMLS:C5959091

object_name: Adult Solid Neoplasm


subject: UMLS:C5959091

object_name: Solid Neoplasm


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: peripheral arterial disease


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C0020852

subject_name: immunoglobulin G

object_name: epidermolysis bullosa


subject: UMLS:C0020852

object_name: recessive dystrophic epidermolysis bullosa


subject: UMLS:C0020852

object_name: epidermolysis bullosa dystrophica


subject: UMLS:C0020852

object_name: acquired epidermolysis bullosa


subject: UMLS:C3536873

subject_name: Immunoglobulin G [EPC]


subject: UMLS:C3536873


subject: UMLS:C3536873


subject: UMLS:C3536873


subject: UMLS:C3474339

subject_name: mirabegron 50 MG Extended Release Oral Tablet

object_name: Finding relating to sexuality and sexual activity


subject: UMLS:C3474339

object_name: Urinary Urgency


subject: UMLS:C3474339

object_name: Psychosexual dysfunction


subject: UMLS:C5417863

subject_name: Radix Polygalae Extract PDC-1421

object_name: endogenous depression


subject: UMLS:C5417863

object_name: major depressive disorder


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: periodontal disorder


subject: CHEBI:9907

subject_name: ursodiol

object_name: obstructive jaundice


subject: CHEBI:92511

subject_name: Ketotifen

object_name: COVID-19 respiratory infection


subject: CHEBI:49662

subject_name: Indomethacin


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)

object_name: psoriasis


subject: PR:000010755


subject: MESH:C112734

subject_name: AIDSVAX

object_name: HIV Seronegativity


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Axial Spondyloarthritis


subject: CHEBI:6741

subject_name: Meloxicam


subject: CHEBI:59527


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:7476

subject_name: Naproxen


subject: UMLS:C3896931

object_name: Hepatic impairment


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib

object_name: neurodegenerative disease


subject: PUBCHEM.COMPOUND:51038893

object_name: Langerhans cell histiocytosis


subject: PUBCHEM.COMPOUND:51038893

object_name: malignant histiocytosis


subject: PUBCHEM.COMPOUND:51038893

object_name: histiocytic sarcoma


subject: PUBCHEM.COMPOUND:51038893

object_name: sinus histiocytosis with massive lymphadenopathy


subject: PUBCHEM.COMPOUND:51038893

object_name: juvenile xanthogranuloma


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: Presenile dementia


subject: CHEBI:76016

object_name: dementia


subject: CHEBI:17968

subject_name: butyrate

object_name: Pediatric Obesity


subject: MESH:D002087

subject_name: Butyrates


subject: CHEBI:30772

subject_name: Butyric Acid


subject: UMLS:C5565871

subject_name: Paxlovid

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEBI:192712


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Right ventricular failure


subject: CHEBI:681850

subject_name: Conivaptan

object_name: pulmonary hypertension


subject: CHEBI:681850

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:681850


subject: CHEBI:50859

subject_name: Bexarotene

object_name: Cushing Disease


subject: UMLS:C2987384

subject_name: BMN 673

object_name: endometrial cancer


subject: UMLS:C2987384

object_name: uterine corpus cancer


subject: UMLS:C2987384

object_name: endometrial carcinoma


subject: GTOPDB:8313

subject_name: talazoparib


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: UNII:G2283XQ6VJ

object_name: Primary hypercholesterolemia


subject: UNII:G2283XQ6VJ

object_name: hyperlipidemia, familial combined, LPL related


subject: UNII:G2283XQ6VJ

object_name: Mixed hyperlipidemia (disorder)


subject: UNII:G2283XQ6VJ

object_name: Mixed Hyperlipidemia


subject: CHEBI:7772

subject_name: omeprazole

object_name: Peptic Ulcer


subject: CHEBI:7772

object_name: Hemorrhage


subject: CHEBI:77260

subject_name: Omeprazole


subject: UMLS:C2606671

object_name: non-small cell squamous lung carcinoma


subject: CHEBI:6801

subject_name: Metformin

object_name: Posterior Fossa Ependymal Tumor


subject: UNII:7N8K34P2XH

subject_name: Detomidine

object_name: septic shock


subject: CHEBI:74817

subject_name: Ser-Met

object_name: type 2 diabetes mellitus


subject: CHEBI:17076

subject_name: Streptomycin


subject: CHEBI:33374

subject_name: Samarium


subject: UMLS:C1527264

object_name: candidiasis


subject: UMLS:C0251514

subject_name: Acthrel

object_name: pituitary cancer


subject: UMLS:C0251514

object_name: pituitary tumor


subject: CHEBI:23359

subject_name: colchicine

object_name: cerebral atherosclerosis


subject: UMLS:C0042210

subject_name: Vaccines

object_name: hand, foot and mouth disease


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C4287792

object_name: pediatric angiosarcoma


subject: UMLS:C4287792

object_name: angiosarcoma


subject: UMLS:C4287792

object_name: Adult Angiosarcoma


subject: UMLS:C1709400

object_name: Neoplasm Metastasis


subject: CHEBI:132268

subject_name: Dacomitinib


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: anxiety disorder


subject: MESH:C000620181

object_name: osteoarthritis, knee


subject: UMLS:C3273454


subject: UMLS:C3897088

subject_name: Oral Azacitidine

object_name: Classical Hodgkin lymphoma refractory


subject: UMLS:C3897088

object_name: Relapsing classical Hodgkin lymphoma


subject: UNII:3S182ET3UA

subject_name: TINZAPARIN SODIUM

object_name: lung cancer


subject: UNII:3S182ET3UA

object_name: lung neoplasm


subject: CHEBI:6801

object_name: Nonorganic psychosis


subject: CHEBI:6801

object_name: Psychosis, CTCAE


subject: CHEBI:6801

object_name: Cannabis use


subject: CHEBI:90942

subject_name: Ixazomib

object_name: Solid Neoplasm


subject: UMLS:C5691234

object_name: Chronic small plaque psoriasis


subject: CHEMBL.COMPOUND:CHEMBL5095370

subject_name: TULISOKIBART

object_name: Acne inversa


subject: UMLS:C5783740

subject_name: Tulisokibart


subject: CHEBI:173081

subject_name: copanlisib dihydrochloride

object_name: Mantle cell lymphoma refractory


subject: CHEBI:173081

object_name: Mantle cell lymphoma recurrent


subject: UMLS:C4528197

subject_name: Copanlisib dihydrochloride


subject: UMLS:C4528197


subject: CHEBI:7903

subject_name: Pamidronic acid

object_name: Chronic low back pain


subject: UNII:3ZY6J6Z6EE

subject_name: Droxidopa

object_name: end stage renal failure


subject: UNII:3ZY6J6Z6EE

object_name: Chronic uremia


subject: UNII:3ZY6J6Z6EE

object_name: kidney disorder


subject: CHEBI:172923

subject_name: FLUORESCEIN

object_name: digestive system disorder


subject: CHEBI:172923

object_name: Plexosarcoma


subject: CHEBI:172923

object_name: Childhood Gastrointestinal Stromal Tumor


subject: CHEBI:172923

object_name: Stomach cancer


subject: CHEBI:172923

object_name: Childhood Gastric Carcinoma


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green


subject: PUBCHEM.COMPOUND:6096882


subject: PUBCHEM.COMPOUND:6096882


subject: PUBCHEM.COMPOUND:6096882


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UMLS:C3827106

object_name: head and neck squamous cell carcinoma


subject: GTOPDB:8002

subject_name: bavituximab

object_name: rectum adenocarcinoma


subject: UNII:Q16CT95N25


subject: UMLS:C1707382


subject: UNII:DM9UIR23R7

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:DM9UIR23R7

object_name: Waldenstrom macroglobulinemia


subject: UNII:DM9UIR23R7

object_name: acute lymphoblastic leukemia


subject: UNII:DM9UIR23R7

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:DM9UIR23R7

object_name: Myelodysplasia


subject: UNII:DM9UIR23R7

object_name: Adult Myelodysplastic Syndrome


subject: UNII:DM9UIR23R7

object_name: childhood myelodysplastic syndrome


subject: UNII:DM9UIR23R7

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:DM9UIR23R7

object_name: acute myeloid leukemia by FAB classification


subject: UNII:DM9UIR23R7

object_name: acute myeloid leukemia


subject: UNII:DM9UIR23R7

object_name: non-Hodgkin lymphoma


subject: UNII:DM9UIR23R7

object_name: Myeloid Metaplasia


subject: UNII:DM9UIR23R7

object_name: plasma cell myeloma


subject: UNII:DM9UIR23R7

object_name: myelofibrosis


subject: UMLS:C2826371


subject: UMLS:C2826371


subject: UMLS:C2826371


subject: UMLS:C2826371


subject: UMLS:C2826371


subject: UMLS:C2826371


subject: UMLS:C2826371


subject: UMLS:C2826371


subject: UMLS:C2826371


subject: UMLS:C2826371


subject: UMLS:C2826371


subject: UMLS:C2826371


subject: UMLS:C2826371


subject: UMLS:C2826371


subject: CHEBI:15891

subject_name: Taurine

object_name: Cooley's anemia


subject: CHEBI:15891

object_name: beta thalassemia


subject: UMLS:C0699617

subject_name: Norditropin

object_name: Dwarfism


subject: UMLS:C0699617

object_name: Short stature


subject: UMLS:C0699617

object_name: Short Stature, CTCAE


subject: UMLS:C5706374

subject_name: ENPP1 Inhibitor RBS2418

object_name: metastatic colorectal cancer


subject: UNII:48IJA0E92C

subject_name: IFETROBAN SODIUM

object_name: interstitial lung disease 1


subject: UNII:48IJA0E92C

object_name: interstitial lung disease 2


subject: UMLS:C2825686

subject_name: Ifetroban Sodium


subject: UMLS:C2825686


subject: UMLS:C0791514

subject_name: Chlorhexidine Gluconate Solution

object_name: radiodermatitis


subject: CHEBI:7025

subject_name: Mupirocin


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:68534

object_name: clear cell renal carcinoma


subject: CHEBI:68534

object_name: Stage I Renal Cell Cancer AJCC v8


subject: CHEBI:68534

object_name: Stage I Renal Cell Carcinoma


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: diffuse large B-cell lymphoma


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: cystic fibrosis


subject: CHEBI:132082

subject_name: Entinostat

object_name: Endometrial High Grade Endometrioid Adenocarcinoma


subject: CHEBI:132082

object_name: FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma


subject: CHEBI:132082

object_name: FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma


subject: UMLS:C0556082

subject_name: Amino acid supplement

object_name: acute kidney failure


subject: UMLS:C0556082

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: UMLS:C5854504

subject_name: Donitabart

object_name: Childhood Neuroblastoma


subject: UMLS:C5854504

object_name: neuroblastoma


subject: CHEBI:4953

subject_name: Exemestane

object_name: ovarian cancer


subject: CHEBI:4953

object_name: ovarian neoplasm


subject: CHEBI:4953

object_name: ovarian carcinoma


subject: UMLS:C4727735

object_name: Childhood Solid Neoplasm


subject: UMLS:C4727735

object_name: Adult Solid Neoplasm


subject: UMLS:C4727735

object_name: Solid Neoplasm


subject: UMLS:C4727735

object_name: Embolism, Tumor


subject: UMLS:C4727735

object_name: cancer


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: myasthenia gravis


subject: CHEBI:61057

object_name: Myasthenia Gravis, CTCAE


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: PUBCHEM.COMPOUND:4442

subject_name: Ramosetron

object_name: Bowel incontinence


subject: PUBCHEM.COMPOUND:4442

object_name: Fecal Incontinence, CTCAE


subject: UNII:3NU609VYNF

object_name: mild neurocognitive disorder


subject: UNII:3NU609VYNF

object_name: mild cognitive impairment


subject: UNII:3NU609VYNF

object_name: Alzheimer disease type 1


subject: UNII:3NU609VYNF

object_name: Alzheimer disease


subject: UMLS:C5552902

subject_name: Anti-interleukin-1 Beta Monoclonal Antibody FL-101

object_name: non-small cell lung carcinoma


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: migraine


subject: CHEBI:30746

subject_name: Benzoic acid

object_name: Chronic liver disease


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:39585


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: PUBCHEM.COMPOUND:521372


subject: CHEBI:177700

subject_name: Elacytarabine

object_name: adult acute myeloid leukemia


subject: CHEBI:177700

object_name: childhood acute myeloid leukemia


subject: PUBCHEM.COMPOUND:149205919

subject_name: SEVASEMTEN

object_name: Becker muscular dystrophy


subject: UNII:JT5OYR0WUK


subject: PUBCHEM.COMPOUND:3367

object_name: carcinoma of esophagus


subject: PUBCHEM.COMPOUND:3367

object_name: Childhood Synovial Sarcoma


subject: PUBCHEM.COMPOUND:3367

object_name: Adult Synovial Sarcoma


subject: PUBCHEM.COMPOUND:3367

object_name: synovial sarcoma


subject: CHEBI:6121

subject_name: Ketamine

object_name: Out-of-Hospital Cardiac Arrest


subject: UNII:OS7097575K

subject_name: Parsaclisib

object_name: autoimmune hemolytic anemia


subject: UMLS:C1576550

subject_name: Progesterone, Micronized 100 MG Vaginal Kit

object_name: infertility


subject: CHEBI:23965

subject_name: estradiol

object_name: female infertility


subject: CHEBI:7459

subject_name: Naloxone

object_name: Nausea, CTCAE_5


subject: CHEBI:7459

object_name: Nausea


subject: CHEBI:7459

object_name: Nausea, CTCAE_3


subject: CHEBI:7459

object_name: Pruritus, CTCAE


subject: CHEBI:50634

object_name: Hypervolemia


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEMBL.COMPOUND:CHEMBL5314986

subject_name: GLA-AF

object_name: influenza A subtype H5N1 infection


subject: CHEBI:60791

subject_name: Xylocard

object_name: no feeling or sensation of skin


subject: CHEBI:60791

object_name: Sensory Loss


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Metastatic Anal Canal Carcinoma


subject: CHEBI:231679

object_name: anal canal squamous cell carcinoma


subject: CHEBI:231679

object_name: Stage IV Anal Cancer AJCC v8


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:6095520

object_name: carcinoma of esophagus


subject: PUBCHEM.COMPOUND:6095520

object_name: esophageal cancer


subject: PUBCHEM.COMPOUND:6095520

object_name: Childhood Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:6095520

object_name: neoplasm of esophagus


subject: PUBCHEM.COMPOUND:89465

subject_name: Glucal


subject: PUBCHEM.COMPOUND:89465


subject: PUBCHEM.COMPOUND:89465


subject: PUBCHEM.COMPOUND:89465


subject: CHEBI:3309

subject_name: Calcium gluconate


subject: CHEBI:3309


subject: CHEBI:3309


subject: CHEBI:3309


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Medical abortion (finding)


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Unresectable Urothelial Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Advanced Endometrial Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Advanced Cervical Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Advanced Breast Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Advanced Penile Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Advanced Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Advanced Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Advanced gastric carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Advanced Lung Small Cell Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Advanced Lung Non-Small Cell Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Advanced Head and Neck Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Cervical Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Penile Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Penile Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Intrahepatic Bile Duct Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Intrahepatic Bile Duct Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Pleural Malignant Mesothelioma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Pleural Malignant Mesothelioma AJCC v8


subject: UNII:7N13IK9LNH

object_name: Advanced Urothelial Carcinoma


subject: UNII:7N13IK9LNH

object_name: Unresectable Urothelial Carcinoma


subject: UNII:7N13IK9LNH

object_name: Advanced Endometrial Carcinoma


subject: UNII:7N13IK9LNH

object_name: Advanced Cervical Carcinoma


subject: UNII:7N13IK9LNH

object_name: Advanced Breast Carcinoma


subject: UNII:7N13IK9LNH

object_name: Advanced Penile Carcinoma


subject: UNII:7N13IK9LNH

object_name: Advanced Esophageal Carcinoma


subject: UNII:7N13IK9LNH

object_name: Advanced Bile Duct Carcinoma


subject: UNII:7N13IK9LNH

object_name: Advanced Lung Small Cell Carcinoma


subject: UNII:7N13IK9LNH

object_name: Advanced Lung Non-Small Cell Carcinoma


subject: UNII:7N13IK9LNH

object_name: Advanced Head and Neck Carcinoma


subject: UNII:7N13IK9LNH

object_name: triple-negative breast carcinoma


subject: UNII:7N13IK9LNH

object_name: Stage IV Cervical Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage III Cervical Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Pleural mesothelioma malignant advanced


subject: UNII:7N13IK9LNH

object_name: Stage IV Penile Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage III Penile Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage IV Intrahepatic Bile Duct Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage III Intrahepatic Bile Duct Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage IV Distal Bile Duct Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage III Distal Bile Duct Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage III Pleural Malignant Mesothelioma AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage IV Pleural Malignant Mesothelioma AJCC v8


subject: DRUGBANK:DB19041

subject_name: Elimusertib

object_name: Advanced Urothelial Carcinoma


subject: DRUGBANK:DB19041

object_name: Unresectable Urothelial Carcinoma


subject: DRUGBANK:DB19041

object_name: Advanced Endometrial Carcinoma


subject: DRUGBANK:DB19041

object_name: Advanced Cervical Carcinoma


subject: DRUGBANK:DB19041

object_name: Advanced Breast Carcinoma


subject: DRUGBANK:DB19041

object_name: Advanced Penile Carcinoma


subject: DRUGBANK:DB19041

object_name: Advanced Esophageal Carcinoma


subject: DRUGBANK:DB19041

object_name: Advanced Bile Duct Carcinoma


subject: DRUGBANK:DB19041

object_name: Advanced Lung Small Cell Carcinoma


subject: DRUGBANK:DB19041

object_name: Advanced Lung Non-Small Cell Carcinoma


subject: DRUGBANK:DB19041

object_name: Advanced Head and Neck Carcinoma


subject: DRUGBANK:DB19041

object_name: triple-negative breast carcinoma


subject: DRUGBANK:DB19041

object_name: Stage IV Cervical Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage III Cervical Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Pleural mesothelioma malignant advanced


subject: DRUGBANK:DB19041

object_name: Stage IV Penile Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage III Penile Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage IV Intrahepatic Bile Duct Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage III Intrahepatic Bile Duct Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage IV Distal Bile Duct Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage III Distal Bile Duct Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage III Pleural Malignant Mesothelioma AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage IV Pleural Malignant Mesothelioma AJCC v8


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Unresectable Urothelial Carcinoma


subject: CHEBI:175901

object_name: Advanced Endometrial Carcinoma


subject: CHEBI:175901

object_name: Advanced Cervical Carcinoma


subject: CHEBI:175901

object_name: Advanced Breast Carcinoma


subject: CHEBI:175901

object_name: Advanced Penile Carcinoma


subject: CHEBI:175901

object_name: Advanced Esophageal Carcinoma


subject: CHEBI:175901

object_name: Advanced gastric carcinoma


subject: CHEBI:175901

object_name: Advanced Lung Small Cell Carcinoma


subject: CHEBI:175901

object_name: Advanced Lung Non-Small Cell Carcinoma


subject: CHEBI:175901

object_name: Advanced Head and Neck Carcinoma


subject: CHEBI:175901

object_name: Stage IV Cervical Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage III Cervical Cancer AJCC v8


subject: CHEBI:175901

object_name: Pleural mesothelioma malignant advanced


subject: CHEBI:175901

object_name: Stage IV Penile Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage III Penile Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage IV Intrahepatic Bile Duct Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage III Intrahepatic Bile Duct Cancer AJCC v8


subject: CHEBI:175901

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:175901

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: CHEBI:175901

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage III Pleural Malignant Mesothelioma AJCC v8


subject: CHEBI:175901

object_name: Stage IV Pleural Malignant Mesothelioma AJCC v8


subject: CHEBI:10033

subject_name: Warfarin

object_name: arteriosclerosis disorder


subject: CHEBI:10033

object_name: atherosclerosis


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Childhood Anaplastic Oligodendroglioma


subject: UNII:2S9ZZM9Q9V

object_name: anaplastic oligodendroglioma


subject: CHEBI:90237

subject_name: Tandutinib


subject: CHEBI:90237


subject: CHEBI:90237

object_name: Adult Anaplastic Oligodendroglioma


subject: CHEBI:90237

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:90237

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:90237

object_name: anaplastic astrocytoma


subject: CHEBI:90237

object_name: Childhood Glioblastoma


subject: CHEBI:90237

object_name: gliosarcoma


subject: CHEBI:90237

object_name: Childhood Gliosarcoma


subject: UMLS:C1384662


subject: UMLS:C1384662


subject: UMLS:C1384662


subject: UMLS:C1384662


subject: UMLS:C1384662


subject: UMLS:C1384662


subject: UMLS:C1384662

object_name: glioblastoma


subject: UMLS:C1384662


subject: UMLS:C1384662

object_name: adult glioblastoma


subject: UMLS:C1384662

object_name: Adult Gliosarcoma


subject: UMLS:C1384662


subject: UMLS:C1384662


subject: CHEBI:36791

subject_name: Escitalopram

object_name: neoplasm


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:134703

subject_name: Fluciclovine (18F)

object_name: Rejection of pancreas transplant


subject: CHEBI:134703

object_name: Pancreatitis, Graft


subject: UMLS:C3274915

subject_name: Globo H-KLH immunostimulant OPT-822

object_name: Carcinoma breast stage IV


subject: CHEBI:75551


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: coronary stenosis


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: Surgical procedure finding


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:46195

subject_name: Acetaminophen


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:188153

subject_name: Oteseconazole

object_name: tinea pedis


subject: CHEBI:46195

object_name: Sprains and Strains


subject: UMLS:C2917659


subject: CHEBI:59759

subject_name: ethyl hydrogen phosphate(1-)

object_name: nasopharyngeal carcinoma


subject: CHEBI:59759

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:42383

subject_name: Ethylphosphate


subject: CHEBI:42383


subject: CHEBI:34757

subject_name: fenitrothion


subject: CHEBI:34757


subject: PR:000006030

subject_name: procathepsin L


subject: PR:000006030


subject: PR:000011260

subject_name: neurolysin, mitochondrial


subject: PR:000011260


subject: PR:000007133

subject_name: ephrin type-B receptor 6


subject: PR:000007133


subject: CHEMBL.COMPOUND:CHEMBL55643

subject_name: COPPER

object_name: prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL55643

object_name: prostate cancer


subject: CHEBI:28694

subject_name: Copper


subject: CHEBI:28694


subject: CHEBI:29036

subject_name: Cupric cation


subject: CHEBI:29036


subject: CHEBI:31431


subject: CHEBI:31431


subject: CHEBI:173763

subject_name: Thermophillin


subject: CHEBI:173763


subject: PUBCHEM.COMPOUND:23597337

subject_name: Physalin L


subject: PUBCHEM.COMPOUND:23597337


subject: CHEBI:4659

subject_name: Disulfiram


subject: CHEBI:4659


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate

object_name: Complication of ultrasound therapy


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:135530

subject_name: Solifenacin

object_name: urgency urinary incontinence


subject: CHEBI:82718

subject_name: Efinaconazole

object_name: tinea infection


subject: CHEBI:82718

object_name: dermatophytosis


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: hypertrophic cardiomyopathy


subject: CHEBI:28939

object_name: Hypertrophic cardiomyopathy without obstruction


subject: CHEBI:15765

subject_name: Levodopa

object_name: brain disorder


subject: CHEBI:15765

object_name: neurodegenerative disease


subject: CHEBI:15765

object_name: CNS disorder


subject: UNII:RE0V0T1ES0

subject_name: Resmetirom


subject: UMLS:C4764365

subject_name: Patidegib Topical Gel

object_name: nevoid basal cell carcinoma syndrome


subject: CHEBI:60802

subject_name: ropivacaine

object_name: extension of knee


subject: PUBCHEM.COMPOUND:57389748

subject_name: Linagliptin

object_name: Moderate albuminuria


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Reiter Syndrome


subject: PUBCHEM.COMPOUND:46783403

object_name: bowel dysfunction


subject: UMLS:C0717811

subject_name: PedvaxHIB

object_name: meningococcal meningitis


subject: UMLS:C0717811

object_name: meningococcal infection


subject: UMLS:C0717811

object_name: meningitis


subject: UMLS:C0717811

object_name: Meningitis, CTCAE


subject: UMLS:C1579314

subject_name: Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed


subject: CHEBI:143719

subject_name: H. influenzae type B capsular polysaccharide


subject: UMLS:C0876134

subject_name: Prevnar


subject: UMLS:C3536964

subject_name: rotavirus, live, tetravalent vaccine


subject: CHEBI:74088

object_name: hormone receptor-positive breast cancer


subject: CHEBI:74007


subject: CHEBI:73805

subject_name: Ala-Ile


subject: CHEBI:41774

subject_name: Tamoxifen


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Recurrent Childhood Brain Stem Glioma


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881

object_name: Childhood Cerebral Anaplastic Astrocytoma


subject: CHEBI:90881

object_name: childhood spinal cord tumor


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:71957

object_name: non-small cell lung carcinoma


subject: UNII:60ES45KTMK

subject_name: Pilaralisib


subject: UMLS:C3657458


subject: CHEBI:6801

subject_name: Metformin

object_name: chronic disease


subject: CHEBI:6801

object_name: Chronic Disease


subject: CHEBI:63617

subject_name: Pergolide

object_name: schizotypal personality disorder


subject: CHEBI:63617

object_name: personality disorder


subject: CHEBI:84500

subject_name: varenicline

object_name: neurotrophic keratopathy


subject: CHEBI:143658

object_name: Langerhans cell histiocytosis


subject: CHEBI:143658

object_name: Langerhans cell histiocytosis specific to childhood


subject: CHEBI:143658

object_name: Langerhans cell histiocytosis specific to adulthood


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:83766

subject_name: Olaparib

object_name: squamous cell carcinoma


subject: UNII:9E3TOE5RIZ

object_name: Depressed mood


subject: CHEBI:28125

subject_name: Doconexent

object_name: Diabetes


subject: CHEBI:28125

object_name: diabetes mellitus


subject: CHEBI:28125

object_name: hyperlipoproteinemia


subject: CHEBI:28125

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:28125

object_name: Serum lipids high (finding)


subject: CHEBI:36005

subject_name: docosahexaenoic acid


subject: CHEBI:36005


subject: CHEBI:36005


subject: CHEBI:36005


subject: CHEBI:36005


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28689


subject: UMLS:C0017132

subject_name: Gastric Inhibitory Polypeptide

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0017132

object_name: obesity


subject: UMLS:C0017132

object_name: Obesity, CTCAE


subject: CHEBI:80165


subject: CHEBI:80165


subject: CHEBI:80165


subject: CHEBI:47808

subject_name: Sulforaphane

object_name: schizophrenia


subject: CHEBI:230796

subject_name: Orvepitant

object_name: post-traumatic stress disorder


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: mantle cell lymphoma


subject: UNII:5OGS5K699E

subject_name: Merestinib

object_name: colorectal cancer


subject: UNII:5OGS5K699E

object_name: colorectal carcinoma


subject: UNII:5OGS5K699E

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:5OGS5K699E


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: psoriasis


subject: UMLS:C0378942


subject: CHEBI:9150

subject_name: Simvastatin

object_name: euthyroid Graves orbitopathy


subject: CHEBI:9150

object_name: endocrine exophthalmos


subject: CHEBI:9150

object_name: Thyroid associated orbitopathy


subject: UMLS:C0006051

object_name: cerebral palsy


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: chronic rhinosinusitis with nasal polyps


subject: UMLS:C0910794


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: coronary microvascular disorder


subject: CHEBI:15927

object_name: Adverse Childhood Experiences


subject: CHEBI:80343

subject_name: Mecasermin

object_name: hyperinsulinism


subject: CHEBI:80343

object_name: Hyperinsulinemia


subject: CHEBI:50730

subject_name: Montelukast

object_name: exercise-induced bronchoconstriction


subject: UMLS:C5227659

object_name: Inflammation


subject: UMLS:C5227659

object_name: fibrosis


subject: UMLS:C4733486

subject_name: GLSE compound

object_name: lung neoplasm


subject: UMLS:C4733486

object_name: breast neoplasm


subject: UMLS:C4086361

subject_name: Ginseng Compound


subject: UMLS:C4086361


subject: CHEBI:85993

subject_name: Palbociclib

object_name: colorectal cancer


subject: CHEBI:85993

object_name: colon cancer


subject: CHEBI:85993

object_name: Colon Neoplasm


subject: HMDB:HMDB0033240

subject_name: Grevilline B

object_name: in situ carcinoma


subject: PUBCHEM.COMPOUND:41744

subject_name: Valrubicin


subject: CHEBI:177504

subject_name: Butylphthalide

object_name: Lacunar stroke


subject: CHEBI:177504

object_name: brain small vessel disease 3


subject: CHEBI:6062

subject_name: Isosorbide mononitrate

object_name: Acute Ischemic Stroke


subject: CHEBI:188074

object_name: Plasmodium falciparum malaria


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: UMLS:C2703095

object_name: Metastatic Uveal Melanoma


subject: UMLS:C5206610

subject_name: Pegylated Deoxycytidine Analogue DFP-14927

object_name: Childhood Solid Neoplasm


subject: UMLS:C5206610

object_name: Adult Solid Neoplasm


subject: UMLS:C5206610

object_name: Solid Neoplasm


subject: UMLS:C5206610

object_name: cancer


subject: UMLS:C5206610

object_name: neoplasm


subject: DRUGBANK:DB15074

subject_name: Aglatimagene besadenovec

object_name: Borderline Resectable Pancreatic Ductal Adenocarcinoma


subject: CHEBI:65353

subject_name: Lorcaserin

object_name: cocaine dependence


subject: UMLS:C5551220

subject_name: Reset

object_name: Libido, CTCAE


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: dentin sensitivity


subject: UMLS:C0013227

object_name: dental caries


subject: UMLS:C0013227

object_name: Dental Caries, CTCAE


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: MESH:C111486

subject_name: gluma desensitizer


subject: MESH:C111486


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine


subject: UMLS:C0728976


subject: UMLS:C0728976


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C0308718


subject: UMLS:C0308718


subject: UMLS:C1550141

subject_name: control substance


subject: UMLS:C1550141


subject: UMLS:C1550141


subject: CHEBI:91594

object_name: prostate carcinoma


subject: CHEBI:91594

object_name: prostate cancer


subject: UMLS:C0678133

subject_name: Taxol


subject: UMLS:C0678133


subject: UMLS:C0885467

subject_name: Juglans regia preparation

object_name: Dysbiosis


subject: CHEBI:70839

subject_name: Dasatinib

object_name: core binding factor acute myeloid leukemia


subject: CHEBI:70839

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:70839

object_name: Treatment related acute myeloid leukaemia


subject: CHEBI:70839

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:70839

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: CHEBI:70839

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:70839

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:600103

subject_name: daptomycin

object_name: Infection of bloodstream


subject: UNII:HM5641GA6F

subject_name: Oprelvekin

object_name: nasopharyngeal carcinoma


subject: UNII:HM5641GA6F

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C0537668

subject_name: Neumega


subject: UMLS:C0537668


subject: CHEBI:135926

subject_name: Udenafil

object_name: coronary microvascular disorder


subject: GTOPDB:11581

object_name: Advanced cancer


subject: CHEMBL.COMPOUND:CHEMBL4297755


subject: UNII:3HWS7HF5XD

subject_name: Ferric sulfate

object_name: dental caries


subject: UNII:3HWS7HF5XD

object_name: Dental Caries, CTCAE


subject: UNII:3HWS7HF5XD

object_name: pulpitis


subject: MESH:C086631

subject_name: mineral trioxide aggregate


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:17509


subject: CHEBI:17509


subject: CHEBI:17509


subject: CHEBI:10093

subject_name: Yohimbine

object_name: post-traumatic stress disorder


subject: UMLS:C4764024

subject_name: Anti-FolRa ADC STRO-002

object_name: endometrial cancer


subject: UMLS:C4764024

object_name: uterine corpus cancer


subject: UMLS:C4764024

object_name: endometrial carcinoma


subject: UMLS:C4764024

object_name: endometrioid adenocarcinoma


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: Neuroblastoma recurrent


subject: GTOPDB:4942

object_name: Disseminated neuroblastoma


subject: GTOPDB:4942

object_name: Stage 4S neuroblastoma


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: CHEMBL.COMPOUND:CHEMBL3989780

subject_name: SUCRALFATE

object_name: Chronic radiation proctitis


subject: GTOPDB:7055

subject_name: sucralfate


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: chronic kidney disease


subject: UNII:7DR6F86F5U

subject_name: LEPODISIRAN SODIUM

object_name: elevated lipoprotein (a)


subject: UMLS:C5909020

subject_name: Lepodisiran Sodium


subject: UMLS:C3815568


subject: UMLS:C0123677

subject_name: NovoLog

object_name: mild neurocognitive disorder


subject: UMLS:C0123677

object_name: mild cognitive impairment


subject: PUBCHEM.COMPOUND:2269

object_name: cryptosporidiosis


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: RXCUI:857002

subject_name: acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet

object_name: Post-Operative Pain


subject: CHEBI:16947

object_name: Complication of dialysis


subject: CHEBI:16947

object_name: polyp of colon


subject: CHEBI:16947

object_name: colon carcinoma


subject: CHEBI:16947

object_name: colorectal cancer


subject: CHEBI:16947

object_name: colon cancer


subject: CHEBI:16947


subject: CHEBI:50744

subject_name: citrate salt


subject: CHEBI:50744


subject: CHEBI:50744


subject: CHEBI:50744


subject: CHEBI:50744


subject: CHEBI:50744


subject: MESH:D002951

subject_name: Citrates


subject: MESH:D002951


subject: MESH:D002951


subject: MESH:D002951


subject: MESH:D002951


subject: MESH:D002951


subject: CHEBI:133748

subject_name: citrate anion


subject: CHEBI:133748


subject: CHEBI:133748


subject: CHEBI:133748


subject: CHEBI:133748


subject: CHEBI:133748


subject: CHEBI:30769

subject_name: Citric acid


subject: CHEBI:30769


subject: CHEBI:30769


subject: CHEBI:30769


subject: CHEBI:30769


subject: CHEBI:30769


subject: CHEBI:31498

subject_name: Simethicone


subject: CHEBI:31498


subject: CHEBI:31498


subject: CHEBI:31498


subject: CHEBI:31498


subject: UNII:01OUW6MA4L

subject_name: HYLAN G-F 20

object_name: Arthralgia


subject: UNII:01OUW6MA4L

object_name: Arthralgia, CTCAE


subject: UMLS:C0011519

subject_name: Deoxyribonuclease I

object_name: dry eye syndrome


subject: UMLS:C0011519

object_name: Dry Eye, CTCAE


subject: UMLS:C0011519

object_name: Dryness of eye


subject: UMLS:C0011522

subject_name: deoxyribonucleases


subject: UMLS:C0011522


subject: UMLS:C0011522


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: schizophrenia


subject: CHEBI:77260

subject_name: Omeprazole


subject: UMLS:C5227816

object_name: Kinetic tremor


subject: CHEBI:228302

subject_name: Zuranolone


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: Localized Muscle Invasive Bladder Urothelial Carcinoma


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UMLS:C3640943


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Bronchial dysplasia


subject: CHEBI:231614

object_name: Squamous Lung Dysplasia


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: Nasopharyngeal lymphoepithelioma stage III


subject: UNII:M487QF2F4V

object_name: Nasopharyngeal lymphoepithelioma stage I


subject: UNII:M487QF2F4V

object_name: Nasopharyngeal lymphoepithelioma stage II


subject: UNII:M487QF2F4V

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: UNII:M487QF2F4V

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: UNII:M487QF2F4V

object_name: Nasopharyngeal squamous cell carcinoma stage I


subject: UNII:M487QF2F4V

object_name: Nasopharyngeal squamous cell carcinoma stage II


subject: UNII:M487QF2F4V

object_name: Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


subject: UMLS:C1321603

subject_name: INJECTION, AMIFOSTINE, 500 MG ADMINISTERED


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:33353

subject_name: technetium atom

object_name: thyroid tumor


subject: PUBCHEM.COMPOUND:14907381

object_name: Neoplasm of the gastrointestinal tract


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus

object_name: digestive system neoplasm


subject: CHEBI:190410


subject: CHEBI:46345


subject: UMLS:C4287755

subject_name: HER-Vaxx

object_name: esophageal adenocarcinoma


subject: UMLS:C4287755

object_name: lung adenocarcinoma


subject: UMLS:C4287755

object_name: cervical adenocarcinoma


subject: UMLS:C4287755

object_name: adenocarcinoma


subject: UMLS:C4287755

object_name: bile duct adenocarcinoma


subject: UMLS:C4287755


subject: UMLS:C4287755


subject: UNII:PH8858757I

object_name: ulcerative colitis


subject: UNII:PH8858757I

object_name: inflammatory bowel disease 1


subject: UMLS:C4725760

subject_name: Personalized Synthetic Long Peptide Vaccine

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: UMLS:C4725760

object_name: invasive breast carcinoma


subject: UMLS:C4725760

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: DRUGBANK:DB17293


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:7KYP9TKT70


subject: UMLS:C5783443

subject_name: KRAS G12C Inhibitor IBI351

object_name: tumor suppressor gene on chromosome 11


subject: UMLS:C5783443

object_name: non-small cell lung carcinoma


subject: UMLS:C5783443

object_name: lung cancer


subject: UNII:73B0K5S26A

subject_name: Belimumab

object_name: chronic graft versus host disease


subject: CHEBI:37956

subject_name: histamine antagonist

object_name: post-exercise hypotension


subject: UMLS:C0740098

subject_name: Antihistamine brand of Diphenhydramine


subject: UMLS:C0019592

subject_name: Histamine H1 Antagonists


subject: UMLS:C3536809

subject_name: Antihistamine [EPC]


subject: PUBCHEM.COMPOUND:11963629

subject_name: ferryl iron

object_name: blood coagulation disease


subject: PUBCHEM.COMPOUND:11963629

object_name: Abnormal bleeding


subject: PUBCHEM.COMPOUND:11963629

object_name: Hemorrhage


subject: PUBCHEM.COMPOUND:26945

subject_name: Aqua-cem

object_name: acute intermittent porphyria


subject: CHEBI:60799

subject_name: Esketamine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:60799

object_name: obesity


subject: CHEBI:60799

object_name: Obesity, CTCAE


subject: CHEBI:3139

subject_name: bleomycin

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:3139

object_name: CNS metastases


subject: UNII:K72I3DEX9B

subject_name: Zinc citrate

object_name: Glabellar frown lines


subject: CHEBI:3127

subject_name: Bisoprolol

object_name: Prevention problem


subject: UMLS:C0721124

subject_name: Iron Supplement

object_name: Pediatric Obesity


subject: UMLS:C2825025

subject_name: Iron Supplement [EPC]


subject: UMLS:C0051533

subject_name: Am 80

object_name: Urothelial carcinoma recurrent


subject: UMLS:C0051533

object_name: urethra transitional cell carcinoma


subject: UMLS:C0051533

object_name: transitional cell carcinoma


subject: UMLS:C0051533

object_name: renal pelvis/ureter urothelial carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: UMLS:C3886479

object_name: schizophrenia


subject: UMLS:C5908016

subject_name: CDK4 Inhibitor BGB-43395

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5908016

object_name: Hormone receptor positive malignant neoplasm of breast


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: UNII:FIK1414ZI8

subject_name: Odiparcil

object_name: mucopolysaccharidosis type 6


subject: UMLS:C5670042

subject_name: Fluorine F 18 4-Fluoro-1-naphthol

object_name: endocrine gland neoplasm


subject: PUBCHEM.COMPOUND:122173807

subject_name: anidulafungin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:122173807

object_name: obesity


subject: PUBCHEM.COMPOUND:122173807

object_name: Obesity, CTCAE


subject: UMLS:C0532508


subject: UMLS:C0532508


subject: UMLS:C0532508


subject: CHEBI:173554

subject_name: Ethyl 3-mercaptopropanoic acid

object_name: obstructive sleep apnea syndrome


subject: CHEBI:9586

subject_name: Tiagabine


subject: CHEBI:72296

subject_name: Apixaban

object_name: Anticoagulants and Bleeding Disorders


subject: CHEBI:10033

subject_name: Warfarin

object_name: acute myocardial infarction


subject: CHEBI:10033

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:10033


subject: UNII:D2A6T4UH9C

subject_name: Centanafadine

object_name: anxiety


subject: UNII:D2A6T4UH9C

object_name: anxiety disorder


subject: UNII:D2A6T4UH9C

object_name: Anxiety symptoms


subject: UNII:D2A6T4UH9C

object_name: Anxiety, CTCAE 3.0


subject: UNII:D2A6T4UH9C

object_name: Anxiety, CTCAE 5.0


subject: UNII:D2A6T4UH9C

object_name: social phobia


subject: UNII:D2A6T4UH9C

object_name: generalized anxiety


subject: UNII:D2A6T4UH9C

object_name: generalized anxiety disorder


subject: CHEBI:553827

subject_name: Bambuterol

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:553827

object_name: COPD, severe early onset


subject: CHEBI:553827

object_name: chronic obstructive pulmonary disease


subject: MESH:D019433

subject_name: Chickenpox Vaccine

object_name: Immunosuppression


subject: MESH:D019433

object_name: Decreased Immunologic Activity [PE]


subject: UMLS:C0770687

subject_name: Varicella virus live vaccine


subject: UMLS:C0770687


subject: UMLS:C3464497

subject_name: varicella-zoster virus vaccine live (Oka-Merck) strain


subject: UMLS:C3464497


subject: UNII:3YH0N35CE3

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEMBL.COMPOUND:CHEMBL3545101


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Severe Sepsis


subject: CHEBI:50949

subject_name: serotonin uptake inhibitor

object_name: Finding of lactation


subject: UMLS:C0360105

subject_name: Selective Serotonin Reuptake Inhibitors


subject: UMLS:C2911696

subject_name: Serotonin Reuptake Inhibitor [EPC]


subject: UMLS:C1579361

subject_name: Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)


subject: UMLS:C3537046

subject_name: Norepinephrine Reuptake Inhibitor [EPC]


subject: UMLS:C3537046

object_name: Depressed mood


subject: UMLS:C3537213

subject_name: Serotonin and Norepinephrine Reuptake Inhibitor [EPC]


subject: UMLS:C3537213


subject: PUBCHEM.COMPOUND:155234713

subject_name: sevabertinib

object_name: cancer


subject: PUBCHEM.COMPOUND:155234713

object_name: neoplasm


subject: UNII:2A7VPM5RWH

subject_name: SEVABERTINIB


subject: UNII:2A7VPM5RWH


subject: UMLS:C0111208

subject_name: CTLA-4 Antigen

object_name: melanoma


subject: PR:000001852

subject_name: cytotoxic T-lymphocyte protein 4


subject: CHEMBL.COMPOUND:CHEMBL1743003

subject_name: CONATUMUMAB

object_name: Recurrent ovarian cancer


subject: UMLS:C2346822

subject_name: conatumumab


subject: CHEBI:4856

subject_name: Esmolol

object_name: Immune Tolerance


subject: CHEBI:4856

object_name: sympathetic nervous system disorder


subject: CHEBI:4856

object_name: T lymphocyte disorder


subject: CHEBI:4856

object_name: cytokine release syndrome


subject: CHEBI:4856

object_name: Cytokine storm


subject: CHEBI:23503

subject_name: DL-Cycloserine

object_name: multidrug-resistant tuberculosis


subject: CHEBI:40009

subject_name: Cycloserine


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: borderline personality disorder


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Laceration


subject: CHEBI:74705

object_name: Birth Injuries


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: UNII:SWS48LJU3T

subject_name: LIRENTELIMAB

object_name: chronic idiopathic urticaria


subject: UMLS:C4330704


subject: CHEBI:74947

subject_name: Thalidomide

object_name: endometriosis


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: seborrheic dermatitis


subject: CHEBI:136007

subject_name: methylnaltrexone

object_name: Widespread Chronic Pain


subject: CHEBI:136007

object_name: chronic widespread pain


subject: UMLS:C5417942

object_name: Childhood Solid Neoplasm


subject: UMLS:C5417942

object_name: Adult Solid Neoplasm


subject: UMLS:C5417942

object_name: Solid Neoplasm


subject: UMLS:C5417942

object_name: Embolism, Tumor


subject: UMLS:C5417942

object_name: Neoplasm Metastasis


subject: UMLS:C5417942

object_name: Metastasis


subject: UMLS:C5417942

object_name: Metastatic Lesion


subject: UMLS:C5417942

object_name: Locally Advanced Malignant Neoplasm


subject: UMLS:C3714111

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C3714111

object_name: Recurrent Glioblastoma


subject: CHEBI:9168

subject_name: Sirolimus

object_name: unspecified childhood solid tumor, protocol specific


subject: GTOPDB:13606

subject_name: eplontersen

object_name: Transthyretin amyloid cardiomyopathy


subject: UNII:0GRZ0F5XJ6

subject_name: EPLONTERSEN


subject: UMLS:C5856958

subject_name: Anti-CD38 scFv/Anti-DOTA scFv Fusion Protein CD38-SADA

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5856958

object_name: non-Hodgkin lymphoma


subject: UMLS:C5856958

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C5856958

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C3272420

object_name: macular degeneration


subject: UMLS:C3272420

object_name: age-related macular degeneration


subject: UMLS:C3272420

object_name: retinitis pigmentosa 30


subject: UMLS:C3272420

object_name: age related macular degeneration 10


subject: UMLS:C3272420

object_name: wet macular degeneration


subject: UMLS:C3272420

object_name: retinal degeneration


subject: UMLS:C3272420

object_name: glycogen storage disease II


subject: UMLS:C3272420

object_name: retinal disease


subject: UMLS:C3272420

object_name: eye disorder


subject: CHEMBL.COMPOUND:CHEMBL3545401


subject: CHEMBL.COMPOUND:CHEMBL3545401


subject: CHEMBL.COMPOUND:CHEMBL3545401


subject: CHEMBL.COMPOUND:CHEMBL3545401


subject: CHEMBL.COMPOUND:CHEMBL3545401


subject: CHEMBL.COMPOUND:CHEMBL3545401


subject: CHEMBL.COMPOUND:CHEMBL3545401


subject: CHEMBL.COMPOUND:CHEMBL3545401


subject: CHEMBL.COMPOUND:CHEMBL3545401


subject: UMLS:C4519240


subject: UNII:18AP231HUP

subject_name: TEGAVIVINT

object_name: Refractory Desmoid Fibromatosis


subject: UNII:18AP231HUP

object_name: Recurrent Desmoid Fibromatosis


subject: UNII:18AP231HUP

object_name: Osteosarcoma recurrent


subject: UNII:18AP231HUP

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UNII:18AP231HUP

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UNII:18AP231HUP

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UNII:18AP231HUP

object_name: Refractory Hepatoblastoma


subject: UNII:18AP231HUP

object_name: Refractory Ewing Sarcoma


subject: UNII:18AP231HUP

object_name: Non-Hodgkin's lymphoma refractory


subject: UNII:18AP231HUP

object_name: Refractory Osteosarcoma


subject: UNII:18AP231HUP

object_name: Ewing's sarcoma recurrent


subject: UNII:18AP231HUP

object_name: Hepatoblastoma recurrent


subject: UNII:18AP231HUP

object_name: Refractory Malignant Solid Neoplasm


subject: UNII:18AP231HUP

object_name: Refractory Hepatocellular Carcinoma


subject: UNII:18AP231HUP

object_name: Recurrent Malignant Solid Neoplasm


subject: UNII:18AP231HUP

object_name: nephroblastoma


subject: UNII:18AP231HUP

object_name: Wilms tumor


subject: UNII:18AP231HUP

object_name: childhood kidney Wilms tumor


subject: UNII:18AP231HUP

object_name: Recurrent Hepatocellular Carcinoma


subject: UNII:18AP231HUP

object_name: solid pseudopapillary carcinoma of pancreas


subject: UNII:18AP231HUP

object_name: solid pseudopapillary neoplasm of the pancreas


subject: UNII:18AP231HUP

object_name: endometrial carcinoma


subject: UNII:18AP231HUP

object_name: pancreatic ductal adenocarcinoma


subject: UNII:18AP231HUP

object_name: colorectal carcinoma


subject: UNII:18AP231HUP

object_name: ovarian cancer


subject: UNII:18AP231HUP

object_name: ovarian carcinoma


subject: UNII:18AP231HUP

object_name: malignant epithelial tumor of ovary


subject: UNII:18AP231HUP

object_name: Childhood Neuroblastoma


subject: UNII:18AP231HUP

object_name: neuroblastoma


subject: UNII:18AP231HUP

object_name: melanoma


subject: DRUGBANK:DB17109

subject_name: Tegavivint

object_name: Refractory Desmoid Fibromatosis


subject: DRUGBANK:DB17109

object_name: Recurrent Desmoid Fibromatosis


subject: DRUGBANK:DB17109

object_name: Osteosarcoma recurrent


subject: DRUGBANK:DB17109

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: DRUGBANK:DB17109

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: DRUGBANK:DB17109

object_name: Recurrent Non-Hodgkin Lymphoma


subject: DRUGBANK:DB17109

object_name: Refractory Hepatoblastoma


subject: DRUGBANK:DB17109

object_name: Refractory Ewing Sarcoma


subject: DRUGBANK:DB17109

object_name: Non-Hodgkin's lymphoma refractory


subject: DRUGBANK:DB17109

object_name: Refractory Osteosarcoma


subject: DRUGBANK:DB17109

object_name: Ewing's sarcoma recurrent


subject: DRUGBANK:DB17109

object_name: Hepatoblastoma recurrent


subject: DRUGBANK:DB17109

object_name: Refractory Malignant Solid Neoplasm


subject: DRUGBANK:DB17109

object_name: Refractory Hepatocellular Carcinoma


subject: DRUGBANK:DB17109

object_name: Recurrent Malignant Solid Neoplasm


subject: DRUGBANK:DB17109

object_name: nephroblastoma


subject: DRUGBANK:DB17109

object_name: Wilms tumor


subject: DRUGBANK:DB17109

object_name: childhood kidney Wilms tumor


subject: DRUGBANK:DB17109

object_name: Recurrent Hepatocellular Carcinoma


subject: DRUGBANK:DB17109

object_name: solid pseudopapillary carcinoma of pancreas


subject: DRUGBANK:DB17109

object_name: solid pseudopapillary neoplasm of the pancreas


subject: DRUGBANK:DB17109

object_name: endometrial carcinoma


subject: DRUGBANK:DB17109

object_name: pancreatic ductal adenocarcinoma


subject: DRUGBANK:DB17109

object_name: colorectal carcinoma


subject: DRUGBANK:DB17109

object_name: ovarian cancer


subject: DRUGBANK:DB17109

object_name: ovarian carcinoma


subject: DRUGBANK:DB17109

object_name: malignant epithelial tumor of ovary


subject: DRUGBANK:DB17109

object_name: Childhood Neuroblastoma


subject: DRUGBANK:DB17109

object_name: neuroblastoma


subject: DRUGBANK:DB17109

object_name: melanoma


subject: PUBCHEM.COMPOUND:22902865

subject_name: Bevirimat

object_name: HIV infection


subject: CHEBI:2922

subject_name: Auranofin

object_name: ovarian serous tumor


subject: CHEBI:2922

object_name: Recurrent ovarian cancer


subject: CHEBI:9168


subject: CHEBI:38562

subject_name: Fluvastatin

object_name: proteinuria


subject: CHEBI:38562

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:38562

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:38562

object_name: Proteinuria, CTCAE 5.0


subject: GTOPDB:1994

subject_name: relaxin

object_name: heart failure


subject: GTOPDB:1994

object_name: congestive heart failure


subject: CHEMBL.COMPOUND:CHEMBL2107882

subject_name: RELAXIN


subject: CHEMBL.COMPOUND:CHEMBL2107882


subject: UMLS:C0035031

subject_name: Relaxin


subject: UMLS:C0035031


subject: CHEBI:8024

subject_name: Perindopril

object_name: Hypercholesterolemia


subject: CHEBI:2668

subject_name: Amlodipine


subject: CHEBI:92223

subject_name: Abexinostat

object_name: malignant soft tissue neoplasm


subject: CHEBI:92223

object_name: sarcoma


subject: UMLS:C2003604


subject: UMLS:C2003604


subject: UNII:LR3UXN0193

subject_name: Methoxy polyethylene glycol-epoetin beta

object_name: kidney failure


subject: CHEBI:15367

subject_name: Tretinoin

object_name: Photodamaged skin


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Metastatic tumors of the Ewing's family


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:73828

subject_name: Asp-Glu

object_name: venous thromboembolism


subject: CHEBI:73828

object_name: thrombophilia due to thrombin defect


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin

object_name: mansonelliasis


subject: PUBCHEM.COMPOUND:6427057

object_name: Abdominal pain


subject: PUBCHEM.COMPOUND:6427057

object_name: lymphedema


subject: PUBCHEM.COMPOUND:6427057

object_name: Pruritus, CTCAE


subject: PUBCHEM.COMPOUND:6427057

object_name: Pruritus


subject: CHEBI:6078

subject_name: Ivermectin


subject: CHEBI:6078


subject: CHEBI:6078


subject: CHEBI:6078


subject: CHEBI:6078


subject: CHEBI:16664

subject_name: Albendazole


subject: CHEBI:16664


subject: CHEBI:16664


subject: CHEBI:16664


subject: CHEBI:16664


subject: UMLS:C3896791

subject_name: IDH1R132H-Specific Peptide Vaccine PEPIDH1M

object_name: brain neoplasm


subject: UMLS:C3896791

object_name: brain cancer


subject: UMLS:C3896791

object_name: primary brain neoplasm


subject: CHEBI:74854

subject_name: Thr-Asp


subject: CHEBI:74854


subject: CHEBI:74854


subject: UMLS:C3526553

subject_name: diphtheria, tetanus toxoids and acellular pertussis vaccine


subject: UMLS:C3526553


subject: UMLS:C3526553


subject: UMLS:C0305060

subject_name: Tetanus and diphtheria toxoid adsorbed for adult use


subject: UMLS:C0305060


subject: UMLS:C0305060


subject: CHEBI:94531

subject_name: belinostat

object_name: Metastatic Uveal Melanoma


subject: CHEBI:49166

subject_name: fluorodopa F 18

object_name: glioma


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: primary interstitial lung disease specific to childhood


subject: CHEBI:61057

object_name: interstitial lung disease specific to childhood


subject: CHEBI:61057

object_name: Progressive cGVHD


subject: CHEBI:61057

object_name: Progressive Disease


subject: CHEBI:61057

object_name: Progressive Neoplastic Disease


subject: CHEBI:61057

object_name: IMWG Progressive Disease


subject: CHEBI:61057

object_name: irPD (Immune-Related Response Criteria)


subject: CHEBI:61057

object_name: Global Progressive Disease in Viscera


subject: CHEBI:61057

object_name: RECIL PD


subject: CHEBI:61057

object_name: Global Progressive Disease in Skin


subject: CHEBI:61057

object_name: Global Progressive Disease


subject: CHEBI:61057

object_name: Global Progressive Disease in Lymph Nodes


subject: CHEBI:61057

object_name: Global Progressive Disease in Blood


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: UNII:QX45B99R3J

subject_name: Mavacamten

object_name: Heart failure with normal ejection fraction


subject: GTOPDB:9624

subject_name: gimsilumab


subject: CHEMBL.COMPOUND:CHEMBL2109430

subject_name: GIMSILUMAB


subject: UMLS:C5139894


subject: PUBCHEM.COMPOUND:3222

object_name: rheumatoid arthritis


subject: CHEBI:4784

subject_name: Enalapril


subject: UMLS:C0600128

subject_name: Renitec


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Leber hereditary optic neuropathy


subject: CHEBI:6801

subject_name: Metformin

object_name: DNMT3A gene mutation


subject: CHEBI:47554

subject_name: Ethyl chloride

object_name: Irreversible pulpitis


subject: UNII:N824AOU5XV

subject_name: Pegvisomant

object_name: Prediabetes


subject: UNII:N824AOU5XV

object_name: glucose intolerance


subject: UNII:N824AOU5XV

object_name: Impaired glucose tolerance


subject: UNII:N824AOU5XV

object_name: type 2 diabetes mellitus


subject: UNII:N824AOU5XV

object_name: Insulin resistance


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Small cell lung cancer recurrent


subject: UMLS:C5417977

subject_name: Wee1 Kinase Inhibitor Debio 0123


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:9316

subject_name: Sufentanil

object_name: pain agnosia


subject: CHEBI:9316

object_name: Pain insensitivity


subject: CHEBI:9316

object_name: Fetal Diseases


subject: CHEBI:60802

subject_name: ropivacaine


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:5775

subject_name: Hydralazine

object_name: Abnormal left ventricular function


subject: CHEBI:5775

object_name: Acute Heart Failure Related to COVID-19


subject: CHEBI:5775

object_name: Acute heart failure


subject: CHEBI:17632

subject_name: Nitrate


subject: CHEBI:17632


subject: CHEBI:17632


subject: CHEBI:6061

subject_name: Isosorbide dinitrate


subject: CHEBI:6061


subject: CHEBI:6061


subject: CHEBI:5775

object_name: Locally advanced breast cancer


subject: UMLS:C4287729

object_name: pancreatic neoplasm


subject: UMLS:C4287729

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4287729

object_name: malignant pancreatic neoplasm


subject: UMLS:C3827149

object_name: glioblastoma


subject: UMLS:C3827149

object_name: Childhood Glioblastoma


subject: UMLS:C3827149

object_name: adult glioblastoma


subject: UNII:2P3VWU3H10

subject_name: ACTIVATED CHARCOAL

object_name: major depressive disorder


subject: CHEBI:27594

subject_name: Graphite


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: acute myocardial infarction


subject: CHEBI:81579

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:31355

object_name: Homologous Recombination Deficiency


subject: UNII:1S83F4T2WE

subject_name: Mipicoledine

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C3257744

subject_name: picato

object_name: Genital warts


subject: UNII:7686S50JAH

subject_name: ingenol mebutate


subject: CHEBI:681569

subject_name: Clofarabine

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:681569

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:681569

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:C2M78A9V6Z

object_name: diabetic kidney disease


subject: CHEBI:64073

object_name: septic shock


subject: CHEBI:64073

object_name: Inflammation


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UNII:9P1872D4OL


subject: CHEBI:46217

subject_name: L-alanine residue

object_name: diabetic polyneuropathy


subject: CHEBI:158283

subject_name: Ala-Leu-Ala


subject: CHEBI:16449

subject_name: DL-Alanine


subject: CHEBI:17549

subject_name: Aminolevulinic acid


subject: CHEBI:27432

subject_name: linolenic acid


subject: CHEBI:16977

subject_name: Alanine


subject: CHEBI:82717

subject_name: Tedizolid

object_name: Hepatic impairment


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: CHEBI:71464

subject_name: Palmidrol


subject: CHEBI:71464


subject: UMLS:C2078131

subject_name: intralesional corticosteroid injection

object_name: alopecia areata


subject: UMLS:C2078131

object_name: alopecia


subject: CHEBI:41977

subject_name: Daunorubicin

object_name: refractory anemia with excess blasts in transformation


subject: CHEBI:41977

object_name: myelodysplastic syndrome with excess blasts


subject: CHEBI:41977

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:41977

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:41977

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:41977

object_name: chronic myelomonocytic leukemia


subject: CHEBI:93109

subject_name: Semaxanib


subject: CHEBI:93109


subject: CHEBI:93109


subject: CHEBI:93109


subject: CHEBI:93109


subject: CHEBI:93109


subject: CHEBI:91083

subject_name: Romiplostim


subject: CHEBI:91083


subject: CHEBI:91083


subject: CHEBI:91083


subject: CHEBI:91083


subject: CHEBI:91083


subject: CHEBI:3213

subject_name: Bumetanide

object_name: Seizure Related to COVID-19


subject: CHEBI:3213

object_name: epilepsy


subject: CHEBI:3213

object_name: visual epilepsy


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: anesthesia; functional


subject: UMLS:C1874398

subject_name: atropine / neostigmine


subject: DRUGBANK:DB16615

subject_name: Krill oil

object_name: hypercholesterolemia, familial, 1


subject: DRUGBANK:DB16615

object_name: familial hypercholesterolemia


subject: PUBCHEM.COMPOUND:86821


subject: PUBCHEM.COMPOUND:86821


subject: CHEBI:28824

subject_name: stigmasterol


subject: CHEBI:28824


subject: CHEBI:26125

subject_name: phytosterols


subject: CHEBI:26125


subject: CHEBI:27693

subject_name: beta-Sitosterol


subject: CHEBI:27693


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Ventricular arrhythmia


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: Stress


subject: UMLS:C0004149

subject_name: ATGAM

object_name: sickle cell disease


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Renal cancer metastatic


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEMBL.COMPOUND:CHEMBL2108918

subject_name: CHAMOMILE

object_name: chemotherapy-induced oral mucositis


subject: CHEBI:18388

subject_name: Apigenin


subject: PUBCHEM.COMPOUND:44602504

subject_name: Etrasimod

object_name: pyoderma gangrenosum


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Extrahepatic Cholangiocarcinoma


subject: CHEBI:46345

subject_name: Fluorouracil


subject: UMLS:C5847498

subject_name: Irinotecan liposome injection

object_name: Advanced Bile Duct Carcinoma


subject: UMLS:C5847498


subject: UMLS:C5847498

object_name: intrahepatic cholangiocarcinoma


subject: UMLS:C5847498

object_name: gallbladder carcinoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: UMLS:C5557417

subject_name: Enlonstobart


subject: UMLS:C5557417


subject: UMLS:C5557417


subject: UMLS:C5557417


subject: MESH:C000722308

subject_name: NDV-HXP-S COVID-19 vaccine


subject: MESH:C000722308

object_name: severe acute respiratory syndrome (SARS) pneumonia


subject: MESH:C000722308

object_name: viral pneumonia


subject: UMLS:C2976285

subject_name: TAK 438

object_name: Erosive esophagitis


subject: UMLS:C4045974

subject_name: Biosimilars

object_name: chronic kidney disease


subject: UMLS:C4045974

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C4045974

object_name: anemia


subject: UMLS:C4045974

object_name: end stage renal failure


subject: UMLS:C4045974

object_name: Chronic uremia


subject: UNII:KE3U2023NP

subject_name: Poractant alfa

object_name: Premature infant


subject: UNII:KE3U2023NP

object_name: Premature birth


subject: UNII:KE3U2023NP

object_name: patent ductus arteriosus


subject: UMLS:C0875945

subject_name: poractant

object_name: congenital alveolar dysplasia


subject: UMLS:C0875945

object_name: respiratory distress syndrome in premature infants


subject: UMLS:C0875945

object_name: adult acute respiratory distress syndrome


subject: UMLS:C0875945

object_name: newborn respiratory distress syndrome


subject: UMLS:C0875945


subject: UMLS:C0875945


subject: UMLS:C0875945


subject: CHEBI:95165

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Refractory acute myeloid leukemia


subject: CHEBI:41879

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:85993

object_name: Acute lymphoblastic leukemia recurrent


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:91872

object_name: endometrium adenocarcinoma


subject: CHEBI:91872

object_name: Stage III Uterine Corpus Cancer


subject: CHEBI:28748

subject_name: Doxorubicin


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: MESH:C532412

object_name: metastatic prostate carcinoma


subject: UNII:1XQ871489P

subject_name: Fosmanogepix

object_name: Invasive fungal infection


subject: UNII:4T36H88UA7

subject_name: Apalutamide

object_name: salivary gland cancer


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist


subject: UNII:CEGM9YBNGD

subject_name: Selpercatinib

object_name: Stage IV Lung Cancer AJCC v8


subject: UNII:CEGM9YBNGD

object_name: Stage IVA Lung Cancer AJCC v8


subject: UNII:CEGM9YBNGD

object_name: Stage IVB Lung Cancer AJCC v8


subject: UNII:CEGM9YBNGD

object_name: Non-small cell lung cancer recurrent


subject: PUBCHEM.COMPOUND:3844471

subject_name: Irofulven

object_name: liver cancer


subject: PUBCHEM.COMPOUND:3844471

object_name: liver neoplasm


subject: PUBCHEM.COMPOUND:3844471

object_name: Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:3844471

object_name: liver carcinoma


subject: CHEBI:146207

subject_name: palytoxin


subject: UNII:1FI3KTC550

object_name: schizophrenia


subject: MESH:C010070

subject_name: cernilton

object_name: chronic prostatitis


subject: MESH:C010070

object_name: Chronic pelvic pain syndrome


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Inflammation


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5558

subject_name: Guanfacine


subject: CHEBI:5558

object_name: schizoaffective disorder


subject: CHEBI:5558

object_name: schizophrenia 18


subject: UMLS:C0242580

subject_name: Tenex

object_name: Cognitive impairment


subject: UMLS:C0242580


subject: UMLS:C0242580


subject: UMLS:C0242580


subject: PUBCHEM.COMPOUND:18526330

subject_name: Glycyrrhetin

object_name: autoimmune thrombocytopenia


subject: PUBCHEM.COMPOUND:18526330

object_name: thrombocytopenia due to immune destruction


subject: PUBCHEM.COMPOUND:18526330

object_name: autoimmune thrombocytopenic purpura


subject: PUBCHEM.COMPOUND:3230

subject_name: Biosone


subject: PUBCHEM.COMPOUND:3230


subject: PUBCHEM.COMPOUND:3230


subject: CHEBI:30853

subject_name: Enoxolone


subject: CHEBI:30853


subject: CHEBI:30853


subject: UMLS:C4745062

subject_name: DHODH Inhibitor ASLAN003

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4745062

object_name: acute myeloid leukemia


subject: CHEBI:164200

subject_name: Triclosan

object_name: mucositis


subject: CHEBI:29228

subject_name: FLUORIDE


subject: CHEBI:17051

subject_name: Fluoride ion


subject: UMLS:C3541971

subject_name: Fluoride supplements


subject: UMLS:C3714616

subject_name: Fluoride Drug Class


subject: CHEBI:305790

subject_name: thyroxine

object_name: Thyroid dysfunction


subject: CHEBI:305790

object_name: hyperthyroidism


subject: CHEBI:305790

object_name: Hyperthyroidism, CTCAE


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:18332


subject: CHEBI:36976

subject_name: nucleotide

object_name: Nutritional Requirements


subject: CHEBI:73272

subject_name: CANAGLIFLOZIN

object_name: type 1 diabetes mellitus


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: Unresectable Primary Peritoneal Carcinoma


subject: UNII:P0GVQ9A4S5

object_name: Metastatic Primary Peritoneal Carcinoma


subject: UNII:P0GVQ9A4S5

object_name: Unresectable Fallopian Tube Carcinoma


subject: UNII:P0GVQ9A4S5

object_name: Metastatic Breast Carcinoma


subject: UNII:P0GVQ9A4S5

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UNII:P0GVQ9A4S5

object_name: Pancreatic carcinoma non-resectable


subject: UNII:P0GVQ9A4S5

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UNII:P0GVQ9A4S5

object_name: Metastatic Fallopian Tube Carcinoma


subject: UNII:P0GVQ9A4S5

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: UNII:P0GVQ9A4S5

object_name: Unresectable Breast Carcinoma


subject: UNII:P0GVQ9A4S5

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UNII:P0GVQ9A4S5

object_name: stage IV pancreatic cancer


subject: UNII:P0GVQ9A4S5

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: UNII:P0GVQ9A4S5

object_name: Unresectable Ovarian Carcinoma


subject: UNII:P0GVQ9A4S5

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UNII:P0GVQ9A4S5

object_name: Stage IV Ovarian Carcinoma


subject: UNII:P0GVQ9A4S5

object_name: Metastatic BRCA Hereditary Breast Carcinoma


subject: UNII:P0GVQ9A4S5

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:P0GVQ9A4S5

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UNII:P0GVQ9A4S5

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:P0GVQ9A4S5

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UNII:P0GVQ9A4S5

object_name: Unresectable Malignant Solid Neoplasm


subject: UNII:P0GVQ9A4S5

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:P0GVQ9A4S5

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UNII:P0GVQ9A4S5

object_name: Stage III Ovarian Cancer AJCC v8


subject: UNII:P0GVQ9A4S5

object_name: BRCA Hereditary Ovarian Carcinoma


subject: UNII:P0GVQ9A4S5

object_name: BRCA-Associated Malignant Neoplasm


subject: UMLS:C4287697

object_name: Unresectable Primary Peritoneal Carcinoma


subject: UMLS:C4287697

object_name: Metastatic Primary Peritoneal Carcinoma


subject: UMLS:C4287697

object_name: Unresectable Fallopian Tube Carcinoma


subject: UMLS:C4287697

object_name: Metastatic Breast Carcinoma


subject: UMLS:C4287697

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UMLS:C4287697

object_name: Pancreatic carcinoma non-resectable


subject: UMLS:C4287697

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C4287697

object_name: Metastatic Fallopian Tube Carcinoma


subject: UMLS:C4287697

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: UMLS:C4287697

object_name: Unresectable Breast Carcinoma


subject: UMLS:C4287697

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UMLS:C4287697

object_name: stage IV pancreatic cancer


subject: UMLS:C4287697

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: UMLS:C4287697

object_name: Unresectable Ovarian Carcinoma


subject: UMLS:C4287697

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UMLS:C4287697

object_name: Stage IV Ovarian Carcinoma


subject: UMLS:C4287697

object_name: Metastatic BRCA Hereditary Breast Carcinoma


subject: UMLS:C4287697

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C4287697

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UMLS:C4287697

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C4287697

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UMLS:C4287697

object_name: Unresectable Malignant Solid Neoplasm


subject: UMLS:C4287697

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C4287697

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C4287697

object_name: Stage III Ovarian Cancer AJCC v8


subject: UMLS:C4287697

object_name: BRCA Hereditary Ovarian Carcinoma


subject: UMLS:C4287697

object_name: BRCA-Associated Malignant Neoplasm


subject: CHEBI:177298

object_name: Unresectable Primary Peritoneal Carcinoma


subject: CHEBI:177298

object_name: Metastatic Primary Peritoneal Carcinoma


subject: CHEBI:177298

object_name: Unresectable Fallopian Tube Carcinoma


subject: CHEBI:177298

object_name: Metastatic Breast Carcinoma


subject: CHEBI:177298

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:177298

object_name: Pancreatic carcinoma non-resectable


subject: CHEBI:177298

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:177298

object_name: Metastatic Fallopian Tube Carcinoma


subject: CHEBI:177298

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: CHEBI:177298

object_name: Unresectable Breast Carcinoma


subject: CHEBI:177298

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:177298

object_name: stage IV pancreatic cancer


subject: CHEBI:177298

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: CHEBI:177298

object_name: Unresectable Ovarian Carcinoma


subject: CHEBI:177298

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:177298

object_name: Metastatic BRCA Hereditary Breast Carcinoma


subject: CHEBI:177298

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:177298

object_name: Unresectable Malignant Solid Neoplasm


subject: CHEBI:177298

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:177298

object_name: BRCA Hereditary Ovarian Carcinoma


subject: CHEBI:177298

object_name: BRCA-Associated Malignant Neoplasm


subject: CHEBI:176844

subject_name: Niraparib

object_name: Unresectable Primary Peritoneal Carcinoma


subject: CHEBI:176844

object_name: Metastatic Primary Peritoneal Carcinoma


subject: CHEBI:176844

object_name: Unresectable Fallopian Tube Carcinoma


subject: CHEBI:176844

object_name: Metastatic Breast Carcinoma


subject: CHEBI:176844

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:176844

object_name: Pancreatic carcinoma non-resectable


subject: CHEBI:176844

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:176844

object_name: Metastatic Fallopian Tube Carcinoma


subject: CHEBI:176844

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: CHEBI:176844

object_name: Unresectable Breast Carcinoma


subject: CHEBI:176844

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:176844

object_name: stage IV pancreatic cancer


subject: CHEBI:176844

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: CHEBI:176844

object_name: Unresectable Ovarian Carcinoma


subject: CHEBI:176844

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:176844

object_name: Metastatic BRCA Hereditary Breast Carcinoma


subject: CHEBI:176844

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:176844

object_name: Unresectable Malignant Solid Neoplasm


subject: CHEBI:176844

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:176844

object_name: BRCA Hereditary Ovarian Carcinoma


subject: CHEBI:176844

object_name: BRCA-Associated Malignant Neoplasm


subject: CHEBI:6801

subject_name: Metformin

object_name: tuberculosis


subject: UNII:3HP012Q0FH

object_name: diabetic retinopathy


subject: UNII:2H1PA8H1EN

subject_name: Pegaptanib


subject: MESH:D000082082

subject_name: Immune Checkpoint Inhibitors

object_name: Stomach cancer


subject: MESH:D000082082

object_name: gastric cancer


subject: CHEBI:190735

subject_name: Arbaclofen

object_name: autism spectrum disorder


subject: UMLS:C2606108

subject_name: ASA 404

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C2606108

object_name: Embolism, Tumor


subject: UMLS:C2606108

object_name: Neoplasm Metastasis


subject: CHEBI:75934

subject_name: Vadimezan


subject: CHEBI:75934


subject: CHEBI:75934


subject: CHEBI:600103

subject_name: daptomycin

object_name: end stage renal failure


subject: CHEBI:600103

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:126931

object_name: Chronic obstructive pulmonary disease of horses


subject: PUBCHEM.COMPOUND:126931

object_name: COPD, severe early onset


subject: PUBCHEM.COMPOUND:126931

object_name: chronic obstructive pulmonary disease


subject: CHEBI:53237

subject_name: 4-sulfanilamidobenzoic acid


subject: CHEBI:53237


subject: CHEBI:53237


subject: CHEBI:2549

subject_name: Albuterol

object_name: Passive Smoke Exposure


subject: CHEBI:2549

object_name: Air trapping


subject: CHEBI:2549

object_name: Hyperdistention


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: non-small cell lung carcinoma


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: acute myocardial infarction


subject: CHEBI:201431

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: MESH:C587694

object_name: nonpapillary renal cell carcinoma


subject: MESH:C587694

object_name: clear cell renal carcinoma


subject: MESH:C587694

object_name: renal cell adenocarcinoma


subject: MESH:C587694

object_name: renal cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108878

subject_name: THYROID

object_name: parathyroid gland disorder


subject: CHEMBL.COMPOUND:CHEMBL2108878

object_name: thyroid disease


subject: UMLS:C3540038

subject_name: THYROID DIAGNOSTIC RADIOPHARMACEUTICALS


subject: UMLS:C3540038


subject: CHEBI:9584

subject_name: desiccated thyroid extract


subject: UMLS:C0040134

subject_name: thyroid (USP)


subject: UMLS:C0040134


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: erythromelalgia


subject: CHEBI:70714

subject_name: Teflaro

object_name: osteomyelitis


subject: CHEBI:70714

object_name: Bone Infection, CTCAE


subject: PUBCHEM.COMPOUND:72562361

subject_name: Ceftaroline fosamil


subject: MESH:C000631987

object_name: presbycusis


subject: UNII:4AW7F70MZO

subject_name: Dimiracetam

object_name: neuropathy


subject: UNII:UVJ7NL8S2P

subject_name: Imlifidase

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:7514

subject_name: Neostigmine

object_name: Vaginal delivery (finding)


subject: CHEBI:7514

object_name: previous vaginal delivery (history)


subject: CHEBI:7514

object_name: Pregnant


subject: MESH:C000629782

subject_name: talimogene laherparepvec

object_name: trabecular adenocarcinoma


subject: MESH:C000629782

object_name: cutaneous neuroendocrine carcinoma


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec


subject: UNII:07730V90L6


subject: CHEBI:15407

subject_name: Ephedrine

object_name: Control of hip fracture risk


subject: CHEBI:15407

object_name: hip fracture


subject: CHEBI:8093

subject_name: Phenylephrine


subject: CHEBI:8093


subject: CHEBI:230905

subject_name: Ribociclib

object_name: Neoplasm Metastasis


subject: DRUGBANK:DB17695

subject_name: Heterologous human adult liver derived progenitor cells

object_name: urea cycle disorder


subject: DRUGBANK:DB17695


subject: DRUGBANK:DB17695

object_name: carbamoyl phosphate synthetase I deficiency disease


subject: DRUGBANK:DB17695

object_name: citrullinemia


subject: DRUGBANK:DB17695

object_name: citrullinemia type I


subject: UNII:7CND0TX59N

subject_name: Potassium octanoate

object_name: Metastatic non-small cell lung cancer


subject: UNII:7CND0TX59N

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:25646

subject_name: octanoate


subject: CHEBI:25646


subject: CHEBI:28837

subject_name: Caprylic acid


subject: CHEBI:28837


subject: CHEBI:60799

subject_name: Esketamine

object_name: Rett syndrome


subject: CHEMBL.COMPOUND:CHEMBL2107910

subject_name: OLIVE OIL

object_name: cardiovascular disorder


subject: CHEMBL.COMPOUND:CHEMBL2107910

object_name: Diabetes


subject: CHEMBL.COMPOUND:CHEMBL2107910

object_name: diabetes mellitus


subject: DRUGBANK:DB14330

subject_name: Macadamia oil


subject: DRUGBANK:DB14330

object_name: type 2 diabetes mellitus